Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (HIMS)
NYSE:HIMS
Holding HIMS?
Track your performance easily
See the Price Targets and Ratings of:
HIMS Analyst Ratings
Moderate Buy
4 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HIMS Stock 12 Month Forecast
Average Price Target
$21.09
▲(29.31% Upside)
| Highest Price Target$28.00 | Average Price Target$21.09 | Lowest Price Target$13.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Assigned
09/13/24
Citi
Reiterated
08/27/24
Needham
Initiated
08/22/24
Imperial Capital
Downgraded
08/09/24
Truist Financial
Assigned
08/07/24
Seaport Global
Reiterated
08/06/24
Deutsche Bank
Reiterated
08/06/24
Leerink Partners
Reiterated
08/06/24
TD Cowen
Assigned
08/06/24
Piper Sandler
Reiterated
08/06/24
Robert W. Baird
$13
Hold
-20.29%
Downside
Reiterated
08/05/24
Hold Rating on Hims & Hers Health Amid Mixed Financial Signals
Jefferies
$15→$23
Hold
41.02%
Upside
Assigned
06/27/24
Hims & Hers Health (HIMS) Receives a Hold from Jefferies
Canaccord Genuity
$20→$24
Buy
47.15%
Upside
Reiterated
05/21/24
Hims & Hers price target raised to $24 from $20 at CanaccordHims & Hers price target raised to $24 from $20 at Canaccord
Tigress Financial
$19
Buy
16.49%
Upside
Reiterated
02/29/24
Hims & Hers Health: A Strong Buy on Accelerated Growth and Market Positioning
Guggenheim
$15→$17
Buy
4.23%
Upside
Reiterated
02/27/24
We are incrementally more positive on HIMS after a solid 4Q print and even better outlook given by management, Guggenheim analyst Jack Wallace wrote in a research note after the earnings were disclosed on Monday.
Best Analysts Covering Hims & Hers Health
Which Analyst Should I Follow If I Want to Buy HIMS and Sell After:
1 Month
xxx
Success Rate
4/7 ratings generated profit
Average Return
+1.37%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +1.37% per trade.
3 Months
xxx
Success Rate
5/7 ratings generated profit
Average Return
+12.34%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +12.34% per trade.
1 Year
Success Rate
7/7 ratings generated profit
Average Return
+74.20%
reiterated a buy rating 7 months ago
Copying Jack Wallace's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +74.20% per trade.
2 Years
xxx
Success Rate
7/7 ratings generated profit
Average Return
+129.70%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +129.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HIMS Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
3
3
2
1
1
Buy
7
10
11
10
8
Hold
10
11
13
14
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
24
26
25
21
Each month's total comprises the sum of three months' worth of ratings.
HIMS Financial Forecast
HIMS Stock Forecast FAQ
What is HIMS’s average 12-month price target, according to analysts?
Based on analyst ratings, Hims & Hers Health’s 12-month average price target is $21.09.
What is HIMS’s upside potential, based on the analysts’ average price target?
Hims & Hers Health has 29.31% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HIMS a Buy, Sell or Hold?
Hims & Hers Health has a consensus rating of Moderate Buy which is based on 4 buy ratings, 8 hold ratings and 0 sell ratings.
What is Hims & Hers Health’s price target?
The average price target for Hims & Hers Health is $21.09. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $28.00 ,the lowest forecast is $13.00. The average price target represents 29.31% Increase from the current price of $16.31.
The highest analyst price target is $28.00 ,the lowest forecast is $13.00. The average price target represents 29.31% Increase from the current price of $16.31.
What do analysts say about Hims & Hers Health?
Hims & Hers Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of HIMS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.